These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 8571322)

  • 41. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of a monoclonal antibody, D73H, that maps to a highly conserved region on fibrinogen Bbeta chain.
    Rybarczyk BJ; Pereira M; Simpson-Haidaris PJ
    Thromb Haemost; 2000 Jul; 84(1):43-8. PubMed ID: 10928468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for new endothelial cell binding sites on fibrinogen.
    Smith RA; Rooney MM; Lord ST; Mosesson MW; Gartner TK
    Thromb Haemost; 2000 Nov; 84(5):819-25. PubMed ID: 11127863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemical properties of plasma fibrinogens and fibrins from normal and cobalt-treated rabbits].
    Lober M; Krantz S
    Acta Biol Med Ger; 1975; 34?710():1573-88. PubMed ID: 1233845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
    Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
    Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
    J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for fibrin specific monoclonal antibodies: the development of a new procedure.
    Tymkewycz PM; Creighton-Kempsford LJ; Hockley D; Gaffney PJ
    Thromb Haemost; 1992 Jul; 68(1):48-53. PubMed ID: 1514172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
    Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
    Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defective fibrin crosslinking in acute leukemia.
    Rodeghiero F; Barbui T; Dal Belin-Peruffo A; Dini E
    Thromb Haemost; 1984 Dec; 52(3):343-6. PubMed ID: 6531757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions of human fibrinogens with factor XIII: roles of calcium and the gamma' peptide.
    Moaddel M; Farrell DH; Daugherty MA; Fried MG
    Biochemistry; 2000 Jun; 39(22):6698-705. PubMed ID: 10828988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma and platelet fibrinogen differ in gamma chain content.
    Francis CW; Nachman RL; Marder VJ
    Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates.
    Song YC; Sheng D; Taubenfeld SM; Matsueda GR
    Anal Biochem; 1994 Nov; 223(1):88-92. PubMed ID: 7695107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coagulation in the sand crab (Ovalipes bipustulatus).
    Madaras F; Parkin JD; Castaldi PA
    Thromb Haemost; 1979 Aug; 42(2):734-42. PubMed ID: 505375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel assay for factor XIII based on cross-linking of synthetic peptides: analysis of different substrates.
    Kusch M; Grundmann C; Keitel S; Seitz R; König H
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):575-80. PubMed ID: 16988554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of factor XIII in fibroblast proliferation.
    Ueyama M; Urayama T
    Jpn J Exp Med; 1978 Apr; 48(2):135-42. PubMed ID: 568677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
    Kobbervig C; Williams E
    Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.